Press Release, Market Watch
Precision Oncology Company Lantern Pharma's Artificial Intelligence Approach [...]
DALLAS--(BUSINESS WIRE)--Genomics England and Lantern Pharma, a clinical stage pharma [...]
Let’s start a conversation about the future of cancer drug development.
We are a biotech pharma at the intersection of Artificial Intelligence, genomics, and oncology drug development.